Evidence map›Paper›PMID 28187785›Full record

ArticleBMC geriatrics2017

Longevity and gender as the risk factors of methicillin-resistant Staphylococcus aureus infections in southern Poland.

Monika Pomorska-Wesołowska, Anna Różańska, Joanna Natkaniec, Barbara Gryglewska, Anna Szczypta, Mirosława Dzikowska, Agnieszka Chmielarczyk, Jadwiga Wójkowska-Mach

Open access · goldAbstract read
In one paragraph

Article in BMC geriatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Trend determination of methicillin-resistantNorthern clinics of Istanbul · 2025
    Article
  5. Article
  6. Article
  7. A Sequalae of Lineage Divergence inDiagnostics (Basel, Switzerland) · 2023
    Article
  8. Screening of Toxin Genes in Methicillin-ResistantPolish journal of microbiology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Virulence and Drug-Resistance ofInternational journal of environmental research and public health · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Clinical medicine & research · 2019
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Monika Pomorska-WesołowskaDepartment of Microbiology, Analytical and Microbiological Laboratory of Ruda Slaska, KORLAB NZOZ, Ruda Slaska, Poland.
Anna RóżańskaChair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 18 Czysta Street, 31-121, Krakow, Poland. a.rozanska@uj.edu.pl.
Joanna NatkaniecChair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 18 Czysta Street, 31-121, Krakow, Poland.
Barbara GryglewskaDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland.
Anna SzczyptaFaculty of Health and Medical Sciences, Andrzej Frycz-Modrzewski Krakow University, Krakow, Poland.
Mirosława DzikowskaDepartment of Clinical Nursing Jagiellonian University Medical College, Krakow, Poland.
Agnieszka ChmielarczykChair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 18 Czysta Street, 31-121, Krakow, Poland.
Jadwiga Wójkowska-MachChair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 18 Czysta Street, 31-121, Krakow, Poland.
Jagiellonian University · PLAndrzej Frycz Modrzewski Krakow University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe proportion of older people among the general population has risen. Staphylococcus aureus (SA) constitutes a significant problem. Underlying disease and functional debility, predispose the older adult to staphylococcal carriage and infection, specially bloodstream infection and pneumonia.

methodsThis is a retrospective cohort study of older patients with SA infections. We analyzed a database containing the results of laboratory cultures from patients treated in 2013 for SA infections and selected 613 hospitalized and non-hospitalized people aged ≥60 years.

resultsThe prevalence of Methicillin-resistant SA (MRSA) were significantly different in categories of patients: from 14.1% in young old, 19.5% in old old and 26.7 in longevity. MRSA was significantly more frequently reported in cases of pneumonia, 40.4% of SA strains (p < 0.0001, OR 0.3, 95%CI 0.14-0.49). The nosocomial MRSA infections were more common in ICU departments: prevalence 36.8%, than in non-ICU departments: prevalence 17.3% (OR 2.8, 95%CI 1.06-7.34, p = 0.014). Bloodstream infections, which accounted for 6% of all infections, were more frequent in males (p = 0.0231, OR 2.25, 95%CI 1.098-4.604). The greatest increase in antibiotic resistance was related to trimethoprim/sulfamethoxazole (TMP/SXT), which increased to over 80% in the older study groups. All age groups demonstrated increased MIC90 values for glycopeptide and tigecycline. Although strains isolated from patients in all age groups remained sensitive to vancomycin, strains isolated from patients in the old-old and longevity groups demonstrated resistance to teicoplanin. The MIC90 for tigecycline was the highest in the group aged >90 years.

conclusionsMRSA constitutes a significant epidemiological problem in cases of hospital-treated pneumonia. The findings were similar for long-term-care facilities, where MRSA appears to affect male residents in particular, although there were fewer male residents than female residents. The low sensitivity to TMP/SXT of SA strains isolated from the oldest patients indicates potentially serious challenges pertaining to efficacious treatment of SA infections.

Indexed as

LongevityMethicillin-Resistant Staphylococcus aureusAgedAged, 80 and overAnti-Bacterial AgentsCross InfectionFemaleHumansLong-Term CareMaleMiddle AgedPolandPrevalenceRetrospective StudiesRisk FactorsSex DistributionAnti-Bacterial AgentsAntibiotic resistanceInfectionLongevityMRSATrimethoprim/sulfamethoxazole

Identifiers

PMID28187785
PMCPMC5303243
OpenAlexW2587613275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.